Loading cancer entity…
Loading cancer entity…
Clinical trials
86 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06677853 | Timolol Maleate Gel for the Treatment of Infantile Hemangioma | completed | Phase 2 / Phase 3 | 168 | Auson Pharmaceuticals Inc.INDUSTRY | 1 | Nov 7, 2024 | clinicaltrials |
| NCT01685398 | Topical Timolol for Superficial Infantile Hemangioma | completed | Phase 3 | 48 | Mahidol UniversityOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT02342275 |
| Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma |
| completed |
| Phase 3 |
| 377 |
| West China HospitalOTHER |
| 1 |
| Jun 16, 2022 |
| clinicaltrials |
| NCT02505971 | Nadolol Versus Propranolol in Children With Infantile Hemangiomas | completed | Phase 3 | 74 | The Hospital for Sick ChildrenOTHER | 1 | Oct 28, 2020 | clinicaltrials |
| NCT00312520 | Pulse Steroids Versus Oral Steroids in Problematic Hemangiomas of Infancy | completed | Phase 3 | 20 | The Hospital for Sick ChildrenOTHER | 1 | Apr 19, 2018 | clinicaltrials |
| NCT01056341 | Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy | completed | Phase 2 / Phase 3 | 512 | Pierre Fabre DermatologyINDUSTRY | 16 | Dec 10, 2015 | clinicaltrials |
Data updated 22 days agoSource updated Nov 7, 2024source: clinicaltrials